Equity · Healthcare
WST
NYSEWest Pharmaceutical Services (WST)
The line runs 342.53 USD on 3 September through 412.52 USD on 30 October, on a scale from 325 to 425. Days the market did not trade hold the previous close, flat.
- Market cap
- 28.7B USD
- P/E (TTM)
- 46.3
- Revenue, year to Dec 2025
- 3.1B USD
- EPS, diluted, year to Dec 2025
- 6.79 USD
- 52-week range
- 231 USD – 416.21 USD
- Avg volume
- 36.5K
as of Oct 30, 2026
Have West Pharmaceutical Services (WST) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, West Pharmaceutical Services insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Dec 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 15 Sep 2026
Buys 0Sells 4Net sold $5.44MOther filings 6
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Sell | 2,524 | 921K USD |
| 14 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Sell | 2,500 | 888K USD |
| 11 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Sell | 2,500 | 863K USD |
| 08 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Sell | 8,135 | 2.8M USD |
| Sold | 4 open-market sales | 15,659 | $5.44M |
6 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Option exercise | 2,524 | 226K USD |
| 14 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Option exercise | 2,500 | 224K USD |
| 11 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Option exercise | 2,500 | 224K USD |
| 08 Sep 2026 | Favorite Annette FSr. VP & Chief HR Officer | Option exercise | 8,135 | 694K USD |
| 11 Aug 2026 | McMahon Robert W.SVP & Chief Financial Officer | Option exercise | 7,149 | |
| 11 Aug 2026 | McMahon Robert W.SVP & Chief Financial Officer | Tax withheld | 3,109 | 1.1M USD |
Which funds hold West Pharmaceutical Services (WST)?
1 of the 45 institutional funds we track reported a West Pharmaceutical Services position for the quarter ended 30 Sep 2026 — a combined 228K USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 614 | 228K USD | −7.1% |
Have members of Congress traded West Pharmaceutical Services (WST)?
The most recent congressional trade disclosed in West Pharmaceutical Services is a sale by Lisa C. McClain (house, MI), dated 22 Jul 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 22 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 22 days |
| 17 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 57 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 30 days |
| 25 Feb 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 30 days |
| 13 Feb 2025 | Jared Moskowitzhouse · Democrat–FL | Sale | 1K USD–15K USD | 21 days |
| 08 Nov 2024 | Jared Moskowitzhouse · Democrat–FL | Sale | 1K USD–15K USD | 31 days |
| 28 Dec 2023 | Jared Moskowitzhouse · Democrat–FL | Purchase | 1K USD–15K USD | 237 days |
| 28 Dec 2023 | Jared Moskowitzhouse · Democrat–FL | Purchase | 1K USD–15K USD | 25 days |
What has been filed or recorded for West Pharmaceutical Services (WST)?
The filings we hold for West Pharmaceutical Services, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 06 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 13 shares | 5K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 3.02 USD | |
| 30 Sep 2026 | Financials | Total assets | 4.1B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 3.0B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.15 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 1.92 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 6.79 USD | |
| 31 Dec 2025 | Financials | Revenue | 3.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 493.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 6.79 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 1.92 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 1.82 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 1.23 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 6.69 USD |
West Pharmaceutical Services (WST): frequently asked questions
What did West Pharmaceutical Services shares close at?
West Pharmaceutical Services closed at 412.52 USD on 30 Oct 2026, down 0.89% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is West Pharmaceutical Services’ market cap?
West Pharmaceutical Services is worth 28.7B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is West Pharmaceutical Services’ P/E ratio?
West Pharmaceutical Services has a price-to-earnings ratio of 46.3, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is West Pharmaceutical Services’ revenue?
West Pharmaceutical Services reported revenue of 3.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have West Pharmaceutical Services insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, West Pharmaceutical Services insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Dec 2025, show no open-market purchase. A further 6 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own West Pharmaceutical Services?
1 of the 45 funds we track reported a West Pharmaceutical Services position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded West Pharmaceutical Services?
Yes. 9 trades in West Pharmaceutical Services appear in the congressional disclosures we hold; the latest is a sale by Lisa C. McClain (House, MI) dated 22 Jul 2025, filed 13 Aug 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did West Pharmaceutical Services last report earnings?
West Pharmaceutical Services last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 3.02 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings